Skip to main content
. 2023 Oct 23;4(12):1675–1692. doi: 10.1038/s43018-023-00656-2

Extended Data Fig. 4. Cell surface U5 snRNP200 expression on inversion(3) AML patient samples and human patient-derived cell lines.

Extended Data Fig. 4

(a) UMAP overlay comparing normal donor (blue islands) and AML samples for identification of malignant AML cells (top panel, yellow cell islands; bottom panel, orange cell islands) and colorimetric overlays of CD34, CD33, U5 snRNP200, and CD32A. (b) Histograms of U5 snRNP200 expression on U937 cells versus three distinct human inversion(3) AML cell lines (HNT-34, MUTZ3, and YCU-AML1).